- Home
- ZLAB vs ERO Comparison
ZLAB vs ERO Comparison
Compare ZLAB & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- ERO
- Stock Information
- Founded
- ZLAB 2013
- ERO 2016
- Country
- ZLAB China
- ERO Canada
- Employees
- ZLAB N/A
- ERO N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- ERO
- Sector
- ZLAB Health Care
- ERO
- Exchange
- ZLAB Nasdaq
- ERO Nasdaq
- Market Cap
- ZLAB 3.6B
- ERO 1.3B
- IPO Year
- ZLAB 2017
- ERO N/A
- Fundamental
- Price
- ZLAB $36.40
- ERO $16.97
- Analyst Decision
- ZLAB Buy
- ERO Strong Buy
- Analyst Count
- ZLAB 5
- ERO 1
- Target Price
- ZLAB $54.28
- ERO $19.00
- AVG Volume (30 Days)
- ZLAB 886.6K
- ERO 528.7K
- Earning Date
- ZLAB 08-05-2025
- ERO 07-31-2025
- Dividend Yield
- ZLAB N/A
- ERO N/A
- EPS Growth
- ZLAB N/A
- ERO N/A
- EPS
- ZLAB N/A
- ERO 0.18
- Revenue
- ZLAB $418,326,000.00
- ERO $489,554,000.00
- Revenue This Year
- ZLAB $44.07
- ERO $73.94
- Revenue Next Year
- ZLAB $49.13
- ERO $20.16
- P/E Ratio
- ZLAB N/A
- ERO $92.79
- Revenue Growth
- ZLAB 43.72
- ERO 13.24
- 52 Week Low
- ZLAB $16.01
- ERO $9.30
- 52 Week High
- ZLAB $44.34
- ERO $23.40
- Technical
- Relative Strength Index (RSI)
- ZLAB 52.67
- ERO 62.73
- Support Level
- ZLAB $34.79
- ERO $16.53
- Resistance Level
- ZLAB $36.73
- ERO $18.10
- Average True Range (ATR)
- ZLAB 1.23
- ERO 0.66
- MACD
- ZLAB -0.46
- ERO 0.06
- Stochastic Oscillator
- ZLAB 25.91
- ERO 64.69
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.